Next Quarterly Earnings
Tuesday, August 4, 2026
CW 32
After-Hours
In 30 days
Neurocrine Biosciences is a biopharmaceutical company that researches, develops, and markets innovative therapies for neurological, psychiatric, and rare endocrine diseases. The company focuses on improving patients' quality of life through scientific advancements and providing much-needed medicines.